Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.

The Journal of antimicrobial chemotherapy - 1 Sept 2006

Pachón-Ibáñez María E, Fernández-Cuenca Felipe, Docobo-Pérez Fernando, Pachón Jerónimo, Pascual Alvaro

Abstract excerpt

OBJECTIVES: To examine the development of rifampicin resistance in multidrug-resistant Acinetobacter baumannii exposed to rifampicin and the prevention of the appearance of rifampicin-resistant mutants when rifampicin is used in association with imipenem or sulbactam. METHODS: A clinical strain of multidrug-resistant A. baumannii was used to examine the frequency of resistance to rifampicin in vivo, in a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acinetobacter baumannii
Share to Acinetobacter Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple, Bacterial

Share to Drug Therapy, Combination

Share to Imipenem

Share to Microbial Sensitivity Tests

Share to Pneumonia, Bacterial

Share to Rifampin

Source

Identifiers

PMID: 16870647
DOI: 10.1093/jac/dkl303

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.PMID 16870647Read ↗

Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy.Semantic proximity Read ↗

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy.Semantic proximity Read ↗

Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model.Semantic proximity Read ↗

Molecular basis of rifampicin resistance in Haemophilus influenzae.Semantic proximity Read ↗

Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii.Semantic proximity Read ↗

[Selection of resistance mutants and bacteriostatic and bactericidal activity of meropenem and imipenem against Acinetobacter spp].Semantic proximity Read ↗

Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa.Semantic proximity Read ↗

The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia.Semantic proximity Read ↗

Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis.Semantic proximity Read ↗

Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice.Semantic proximity Read ↗

In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strainSemantic proximity Read ↗

Selection of clarithromycin-resistant Mycobacterium avium complex during combined therapy using the beige mouse model.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.